Related Experiment Videos
[Guidelines for the treatment of aneurysmal subarachnoid hemorrhage. A consensus conference]
1Sociedad Argentina de Terapia Intensiva (SATI), Buenos Aires, Argentina. sati@ba.net
Insights
Subarachnoid hemorrhage (SAH) from ruptured aneurysms requires evidence-based treatment guidelines. This consensus conference established therapeutic recommendations based on evidence levels, aiding clinical decision-making for better patient outcomes.
Area of Science:
- Neurology
- Neurosurgery
- Vascular Medicine
Background:
- Subarachnoid hemorrhage (SAH) accounts for 6% of all strokes, with cerebral aneurysms affecting 0.2-9.9% of the population.
- The annual bleeding rate for cerebral aneurysms is 10 per 100,000 inhabitants, highlighting a significant public health concern.
Framework:
- A consensus conference developed evidence-based therapeutic recommendations for aneurysmal SAH.
- Recommendations are graded A (Level I evidence), B (Level II), and C (Levels III-V), with Grade A representing treatment standards.
- Patient severity is assessed using the Hunt and Hess scale upon admission.
Implementation:
- The analysis covers general medical management, cerebral vasospasm treatment, diagnostic procedures, and management of hyponatremia.
- Prevention of seizures is also a key consideration in the treatment protocols.
- Recommendations require adaptation to individual patient needs.
Implications:
- Establishes a framework for standardized, evidence-based treatment of aneurysmal SAH.
- Aims to improve clinical decision-making and patient outcomes in managing this critical condition.
- Provides a foundation for future research and refinement of SAH treatment strategies.
Abstract:
The subarachnoid hemorrhage (SAH) by aneurysmatic rupture is responsible for 6% of the cerebral vascular accidents. The cerebral aneurysms are present in 0.2-9.9% of the population and the bleeding rate is of 10 out of 100,000 inhabitants per year. The consensus conference analyzed the different schemes of treatment and made therapeutic recommendations according to the criteria of medicine based on evidence. Levels of evidence were determined from I to V. The recommendation degrees were classified in: A, determined by evidence level I, B by evidence level II, and C suggested by evidence levels III, IV and V. These recommendations should be adapted to each patient. However, grade A recommendations are treatment standards. Seriousness of patients was evaluated on the basis of Hunt and Hess scale upon admission. Successive analyses covered: general medical treatment measures, cerebral vasospasm, diagnostic procedures and treatment of the hyponatremia and convulsion prevention.